Marinus selling rare pediatric disease priority review voucher for $110M By: Philadelphia Business Journal via Business Journals July 14, 2022 at 11:07 AM EDT The FDA awarded the Radnor company the lucrative voucher after its seizure drug Ztalmy was approved in March. Read More >>
